Compare FFIC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FFIC | NPCE |
|---|---|---|
| Founded | 1929 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 510.6M | 432.3M |
| IPO Year | 1996 | 2021 |
| Metric | FFIC | NPCE |
|---|---|---|
| Price | $15.87 | $15.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $16.80 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 196.6K | 165.9K |
| Earning Date | 04-24-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.45% | N/A |
| EPS Growth | ★ 151.43 | 29.03 |
| EPS | ★ 0.54 | N/A |
| Revenue | $7,455,000.00 | ★ $99,986,000.00 |
| Revenue This Year | $14.57 | $0.90 |
| Revenue Next Year | $6.64 | $24.46 |
| P/E Ratio | $29.85 | ★ N/A |
| Revenue Growth | 7.31 | ★ 25.13 |
| 52 Week Low | $11.13 | $7.56 |
| 52 Week High | $17.79 | $18.97 |
| Indicator | FFIC | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 54.33 | 62.07 |
| Support Level | $14.47 | $15.25 |
| Resistance Level | $16.65 | $15.71 |
| Average True Range (ATR) | 0.35 | 0.67 |
| MACD | 0.08 | 0.22 |
| Stochastic Oscillator | 62.50 | 91.26 |
Flushing Financial Corp is a bank holding company. Through its subsidiary, the company is engaged in attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, mainly in originations and purchases of multi-family residential properties loans, commercial business loans, commercial real estate mortgage loans and, to a lesser extent, one-to-four family loans (focusing on mixed-use properties, which are properties that contain both residential dwelling units and commercial units). It also operates an internet branch, under the brands of iGObanking.com and BankPurely. The company operates as a single unit, a community bank.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.